About
Plant Substance Drug Delivery
Areas of Focus
Categories
Drug Delivery & Formulation
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
8
As Collaborator
0
Total Enrollment
4,464
By Phase
PHASE3: 8
By Status
UNKNOWN: 8
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT06071936Lead Sponsor
Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy
PHASE3Unknown
558 participants
Started: Nov 2, 2023 · Completed: Dec 31, 2024
NCT06071949Lead Sponsor
Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis
PHASE3Unknown
558 participants
Started: Nov 2, 2023 · Completed: Dec 31, 2024
NCT06071962Lead Sponsor
Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Back Pain
PHASE3Unknown
558 participants
Started: Nov 2, 2023 · Completed: Dec 31, 2024
NCT06071975Lead Sponsor
Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy
PHASE3Unknown
558 participants
Started: Nov 2, 2023 · Completed: Dec 31, 2024
NCT06071988Lead Sponsor
Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy
PHASE3Unknown
558 participants
Started: Nov 2, 2023 · Completed: Dec 31, 2024
Locations (1)
Headquarters
Warngau, Germany
Map
Loading map...